Intestinal Barrier in Post-Campylobacter jejuni Irritable Bowel Syndrome

被引:11
|
作者
Omarova, Sholpan [1 ]
Awad, Karem [1 ]
Moos, Verena [2 ]
Puening, Christoph [3 ]
Goelz, Greta [3 ]
Schulzke, Jorg-Dieter [1 ,2 ]
Buecker, Roland [1 ]
机构
[1] Charite Univ Med Berlin, Campus Benjamin Franklin, Clin Physiol, D-12203 Berlin, Germany
[2] Charite Univ Med Berlin, Campus Benjamin Franklin, Dept Gastroenterol Infect Dis & Rheumatol, D-12203 Berlin, Germany
[3] Free Univ Berlin, Inst Food Safety & Food Hyg, Ctr Vet Publ Hlth, Dept Vet Med, D-14163 Berlin, Germany
关键词
Campylobacter jejuni; irritable bowel syndrome; post-infectious irritable bowel syndrome; barrier function; permeability; antigen entry; leaky gut; tight junction; endocytosis; transcytosis; cytokine; TIGHT JUNCTIONS; TEMPERATURE; TRICELLULIN; EXPRESSION; TRANSPORT; PEPTIDES; CELLS; COLI; GUT;
D O I
10.3390/biom13030449
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Campylobacter jejuni (C. jejuni) is one of the most common causes of bacterial gastroenteritis worldwide. One sequela of this infection is the development of post-infectious irritable bowel syndrome (PI-IBS). It has been suggested that a dysfunctional intestinal barrier may promote IBS development. We aimed to test this hypothesis against the background of the leaky gut concept for low-grade inflammation in PI-IBS. Methods: We identified patients with persistent PI-IBS symptoms after C. jejuni infection. During sigmoidoscopy, forceps biopsies were obtained for electrophysiological measurements of epithelial transport and barrier function in miniaturized Ussing devices. C. jejuni absence was checked by PCR and cytokine production with immunohistochemistry. Results: In PI-IBS, the epithelial resistance of the colon epithelium was unaltered, reflecting an intact paracellular pathway. In contrast, temperature-dependent horseradish peroxidase (HRP, 44 kDa) permeation increased. Short-circuit current (Isc) reflecting active anion secretion and ENaC-dependent electrogenic sodium absorption was unaffected. Early endosome antigen-1 (EEA1) and IL-4 levels increased. C. jejuni is not incorporated into the resident microbiota of the colon mucosa in PI-IBS. Conclusions: In PI-IBS after C. jejuni infection, macromolecule uptake via endocytosis was enhanced, leading to low-grade inflammation with pro-inflammatory cytokine release. The findings will allow C. jejuni-induced pathomechanisms to be targeted during infection and, thereafter to reduce sequelae such as PI-IBS.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Losartan improves visceral sensation and gut barrier in a rat model of irritable bowel syndrome
    Nozu, Tsukasa
    Miyagishi, Saori
    Nozu, Rintaro
    Takakusaki, Kaoru
    Okumura, Toshikatsu
    NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32 (06)
  • [32] miRNA-based therapies for the irritable bowel syndrome
    Zhou, Qiqi
    Verne, G. Nicholas
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (08) : 991 - 995
  • [33] MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome
    Zhou, QiQi
    Souba, Wiley W.
    Croce, Carlo M.
    Verne, G. Nicholas
    GUT, 2010, 59 (06) : 775 - 784
  • [34] Electroacupuncture Improving Intestinal Barrier Function in Rats with Irritable Bowel Syndrome Through Regulating Aquaporins
    Xueling Kang
    Honglin Zhang
    Xiaying Li
    Kai Zhang
    Zhansheng Huang
    Yuanyuan Li
    Xiaoxuan Ren
    Yemao Chai
    Digestive Diseases and Sciences, 2024, 69 : 1143 - 1155
  • [35] Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity
    Laura Prospero
    Giuseppe Riezzo
    Michele Linsalata
    Antonella Orlando
    Benedetta D’Attoma
    Marta Di Masi
    Manuela Martulli
    Francesco Russo
    BMC Gastroenterology, 21
  • [36] Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity
    Prospero, Laura
    Riezzo, Giuseppe
    Linsalata, Michele
    Orlando, Antonella
    D'Attoma, Benedetta
    Di Masi, Marta
    Martulli, Manuela
    Russo, Francesco
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [37] Small intestinal bacterial overgrowth syndrome and irritable bowel syndrome
    Gasiorowska, Joanna
    Czerwionka-Szaflarska, Mieczyslawa
    PRZEGLAD GASTROENTEROLOGICZNY, 2013, 8 (03): : 165 - 171
  • [38] WenTongGanPi decoction alleviates diarrhea-predominant irritable bowel syndrome by improving intestinal barrier
    Li, Yaoguang
    Chen, Yangyang
    Liao, Zhengyue
    Liu, Yixin
    Liu, Chenhao
    Yang, Wenjing
    Bai, Jing
    Huang, Xinggui
    Hao, Yule
    Liu, Sijing
    Liu, Yi
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 334
  • [39] Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids
    Han, Xu
    Lee, Allen
    Huang, Sha
    Gao, Jun
    Spence, Jason R.
    Owyang, Chung
    GUT MICROBES, 2019, 10 (01) : 59 - 76
  • [40] Post-infectious irritable bowel syndrome
    Rhodes D.Y.
    Wallace M.
    Current Gastroenterology Reports, 2006, 8 (4) : 327 - 332